Effect of Physiotherapy in Hospitalized COPD Patients
Effect of Different Physiotherapy Treatments in Hospitalized COPD Patients
Chronic obstructive pulmonary disease (COPD) impacts negatively on the balance and strength of patients. Several studies have shown that acute exacerbations (AEs) decrease, pulmonary function and survival of COPD patients, and there are a lot of physiotherapy interventions to improve it during the hospital stay.
The objective of the present study is to examine the effects of a physical therapy program on balance and strength in COPD patients hospitalized due to acute exacerbation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. It is a progressive disease, characterized by lung function impairment with airway obstruction.
Patients with COPD suffer exacerbations; the frequency of these exacerbations increases with the severity of the disease. It has been previously shown that the level of health-related quality of life of COPD subjects deteriorates considerably with increasing severity of disease and that the deterioration is linearly related to a decrease in FEV1 % predicted normal values.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Granada, Espagne, 18071
- Department of Physical Therapy
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- COPD diagnosis with exacerbation.
- No contraindication of physiotherapy.
- Signed written consent.
- Medical approval for inclusion.
Exclusion Criteria:
- Contraindications for physiotherapy
- Neurological, orthopedic or heart disease
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Experimental group 1
patients will be involved in the Physiotherapy program 1.
The program included 15 minutes of deep breathing exercises and 20-30 minutes of limb exercises.
The exercises included global active range of motion (ROM) exercises and muscle strengthening like upper and lower limbs flexion-extension do single-leg stance, and sit to stand exercises added to standard treatment.
|
The standard medical treatment and additionally they will receive physiotherapy.
The program will be performed every day during the hospital stay and it will include global active range of motion (ROM) exercises and muscle strengthening like upper and lower limbs flexion-extension do single-leg stance, and sit to stand exercises.
Autres noms:
|
|
Expérimental: Experimental group 2
patients will be involved in the physiotherapy program 2. The program was a combined intervention including the Control Group treatment plus neuromuscular stimulation therapy on quadriceps accompanied by lower limb exercises.
|
COPD patients included in this group will receive the standard medical treatment and additionally, they will receive a physiotherapy program.
The program will be performed every day during the hospital stay and included neuromuscular stimulation therapy on quadriceps accompanied by lower limbs exercises
Autres noms:
|
|
Autre: Control group
patients will receive standard medical treatment without physiotherapy intervention.
|
The standard medical treatment consists on:
Inhaled glucocorticoids including beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate and triamcinolone acetonide, depending on the expert criteria. - Antibiotics: The antibiotics were administered according to the GOLD criteria including the β-lactamase inhibitor and fluoroquinolones.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Lower limb strength
Délai: Participants will be followed for the duration of hospital stay, an expected average of 9 days.
|
Lower limb strength was evaluated by a dynamometer.
The assessor placed the limb to be examined in the starting position (a knee flexion of 90º) and instructed each participant to hold the limb in that position against the increasing resistance applied to it by the examiner.
During each test the assessor counted out loud for seconds and at the end of the test period advised the participant to relax the limb.
|
Participants will be followed for the duration of hospital stay, an expected average of 9 days.
|
|
Balance
Délai: Participants will be followed for the duration of hospital stay, an expected average of 9 days.
|
Balance was evaluated by the one-leg standing balance test, that measured the time that the patient balance on one leg as long as possible.
We asked the subject being tested to choose a leg to stand on (whichever he felt more comfortable with), flex the opposite knee allowing the foot to clear the floor, and balance on one leg as long as possible
|
Participants will be followed for the duration of hospital stay, an expected average of 9 days.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Respiratory function
Délai: Participants will be followed for the duration of hospital stay, an expected average of 9 days.
|
Spirometry is regarded as the gold standard measure of respiratory function.
The indicators of forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) will be tested.
Spirometry will be performed according to American Thoracic Society (ATS) criteria.
|
Participants will be followed for the duration of hospital stay, an expected average of 9 days.
|
|
Anxiety and depression
Délai: Participants will be followed for the duration of hospital stay, an expected average of 9 days.
|
The hospital anxiety and depression scale (HADS) will be used to evaluate psychological status.
HADS is a 14-items self-report questionnaire designed to detect psychological morbidity in medically ill patients.
It contains depression and anxiety subscales, each with scores ranging from 0 to 21.
|
Participants will be followed for the duration of hospital stay, an expected average of 9 days.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .